SURF
Surface Oncology Inc
Price:  
1.07 
USD
Volume:  
1,509,170.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SURF WACC - Weighted Average Cost of Capital

The WACC of Surface Oncology Inc (SURF) is 7.2%.

The Cost of Equity of Surface Oncology Inc (SURF) is 8.00%.
The Cost of Debt of Surface Oncology Inc (SURF) is 7.00%.

Range Selected
Cost of equity 6.80% - 9.20% 8.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.3% - 8.0% 7.2%
WACC

SURF WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.39 0.39
Cost of debt 7.00% 7.00%
After-tax WACC 6.3% 8.0%
Selected WACC 7.2%